Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 420.1	$ 415.8
Accounts receivable, less allowance for credit losses	1,418.0	1,442.4
Inventories	2,369.9	2,385.2
Prepaid expenses and other current assets	431.4	366.1
Total Current Assets	4,639.4	4,609.5
Property, plant and equipment, net	2,103.0	2,060.4
Goodwill	8,824.5	8,818.5
Intangible assets, net	4,707.4	4,856.4
Other assets	1,245.7	1,152.1
Total Assets	21,520.0	21,496.9
Current Liabilities:
Accounts payable	341.8	410.6
Other current liabilities	1,388.6	1,546.9
Current portion of long-term debt	1,878.0	900.0
Total Current Liabilities	3,608.4	2,857.4
Other long-term liabilities	1,205.4	1,283.4
Long-term debt	3,956.7	4,867.9
Total Liabilities	8,770.6	9,008.7
Commitments and Contingencies (Note 15)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 317.2 million shares as of June 30, 2024 (316.2 million as of December 31, 2023) issued	3.2	3.2
Paid-in capital	9,974.9	9,846.1
Retained earnings	10,702.5	10,384.5
Accumulated other comprehensive loss	(195.2)	(191.0)
Treasury stock, 112.3 million shares as of June 30, 2024 (110.6 million as of December 31, 2023)	(7,744.3)	(7,562.3)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,741.1	12,480.5
Noncontrolling interest	8.4	7.7
Total Stockholders' Equity	12,749.4	12,488.1
Total Liabilities and Stockholders' Equity	$ 21,520.0	$ 21,496.9